Introduction
============

The sympathetic nervous system regulates the balance in many homeostatic mechanisms, such as gut motility and pupil diameter, and is responsible for priming the body for action, particularly in dangerous situations. Moreover, sympathetic system stimulation causes vasoconstriction of most blood vessels. So thoracic sympathetic nerves, as important parts of sympathetic system, are involved in the treatment of multiple diseases. Currently, endoscopic thoracic sympathectomy is indicated mainly for primary hyperhidrosis, especially that of the palm [@B1], axilla, and the face [@B2],[@B3]. Despite the development of modern pharmacological and endovascular treatments, sympathetic surgery still plays a critical role in the treatment of specific cardiac conditions, such as angina [@B4], long QT syndrome [@B5], and ventricular tachycardia [@B6]. In addition, thoracic sympathetic ablation is indicated for a few painful conditions and ischemia, such as pancreatic pain [@B7], complex regional pain syndrome [@B8], Raynaud\'s phenomenon [@B9], and digital ischemia [@B10],[@B11]. Therefore, accurate intraoperative recognition of the thoracic sympathetic nerves is critical for the treatment of related diseases and for the development of new therapies.

Although the slender white-colored sympathetic chain often can be seen underneath the parietal pleura paralleling the vertebral column and above the heads of the ribs, its size and width are variable. In addition, its cephalad-caudal course may be meandering or straight. So far, no ganglion has clearly been visualized [@B12]. Although there are several anatomic landmarks that surgeons use as guides to identify the thoracic sympathetic chain or ganglion during surgery, the International Society on Sympathetic Surgery and the Society of Thoracic Surgeons recommend using a rib-oriented nomenclature [@B2]. In general, each thoracic ganglion lies in the intercostal space between its corresponding ribs and is referred to based on the anatomical structure. Therefore, surgeons indirectly and roughly determine the locations of the ganglia by counting the ribs at the time of surgery. However, this method has some limitations. Some studies have confirmed that anatomic variations often cause changes in the corresponding spatial locations between thoracic ganglia and the ribs. For example, Street *et al.* found in their series that 6.25% of ganglions were located below their associated intercostal spaces rather than within their corresponding intercostal space. In addition, the stellate ganglion (SG), which was formed by the inferior cervical ganglion and the first thoracic ganglion (T1), was present in only 70% of specimens [@B13]. Chung *et al.* have reported that the SG and the second thoracic ganglion (T2) are fused in 9.1% of patients [@B14]. Failure in the accurate identification of thoracic ganglia may result in operation failure and severe complications [@B2], [@B15].

Fluorescence imaging (FI) is a novel intraoperative imaging modality used to help guide the surgeon in the detection of benign and/or malignant tissues [@B16], and has been used for the detection and treatment of multiple diseases, such as ovarian cancer using specific FI [@B17], head and neck cancer [@B18] and peritoneal carcinomatosis from colorectal cancer [@B19],[@B20] using non-specific FI. However, only a few FI studies of nerves in the clinical have been reported. Wagner *et al.* identified the contralateral periocardiophrenic neurovascular bundle by fluorescing the pericardiophrenic vessels during robotic thymectomy [@B21]. Chen *et al.* recognized facial nerve by highlighting the vessels inside the vasa nervorum during mastoidectomy [@B22]. Our team first reported that thoracic ganglia can be directly visualized during thoracoscopic indocyanine green (ICG) fluorescence guided surgery (ICG-FGS) in a case report [@B23],[@B24]. Notably, ICG has been authorized by the Food and Drug Administration (FDA) for determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography.

In this study, we firstly evaluated the feasibility of intraoperative real-time imaging of thoracic sympathetic nerves (ITSN) with ICG and explored the relationship between the signal to background ratio (SBR) and the injection time of ICG and that between SBR and the dose of ICG using a rabbit model. Because sympathetic nerves were subtle and difficult to detect, a fluorescence microscope system was developed. Then, to study the validity of this method, we carried out a clinical trial with our self-developed near-infrared (NIR) and white-light dual-channel thoracoscope system in Peking University People\'s Hospital.

Materials and Methods
=====================

Fluorescence Microscope System
------------------------------

We developed a modified fluorescence microscope system (Fig. [1](#F1){ref-type="fig"}A) in-house. Briefly, a traditional stereomicroscope (Leica M205 FA, Germany) was coupled with a color camera and an NIR scientific complementary metal-oxide-semiconductor (SCMOS) camera (pco.edge 5.5 m). An NIR laser source (center wavelength: 785 nm, maximum power: 800 mW) was combined with an optical filter module installed in the stereomicroscope through a uniform fiber, so that a specified wavelength of light was transmitted onto the imaging target. The emission light radiated by the excited fluorophore was first filtered by the filter module and then captured by the NIR camera. Similarly, the color camera captured visible images illumined by the light emitting diode. This system was able to produce a strong and noise-free fluorescence image against the background and a bright and high-resolution visible image.

Fluorescence Endoscopic Imaging System
--------------------------------------

The NIR (800-900 nm) and white-light (400-650 nm) dual-channel thoracoscope system was developed by the Key Laboratory of Molecular Imaging of the Chinese Academy of Sciences on the basis of our previous studies [@B25]-[@B29]. A picture of the novel system is presented in Fig. [3](#F3){ref-type="fig"}A. Briefly, the system consisted of four modules: the light-source module, the detector module, the control module, and the display module. The spatial resolution of the system was 35 μm and the minimal detectable ICG concentration was 0.01 μM.

In addition to the ergonomic improvements compared to our previous system [@B27], the novel system used a custom prism with a 30° viewing angle. The use of this prism not only made probing the thoracic sympathetic nerve more convenient, but also resulted in a large aperture and a wide field. Due to the presence of high levels of noise and the weak fluorescence signal during this experiment, we designed a new image enhancement algorithm to improve the qualities of the color and fluorescence images. This system also had improved quantitative analysis functionality, which enabled us to perform the quantitative statistical analysis of the fluorescence intensity and the calculation of SBR in real-time. The quantification techniques of fluorescence intensity signal included fluorescence signal extraction based on fuzzy C-mean clustering and level-set algorithms, fluorescence intensity distribution analysis, the radiometric calculation of fluorescence image and other conventional image analysis methods.

Animals
-------

Four male and six female Japanese white rabbits (weight: 1.75-2.4 kg, average: 2.15 kg) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (China). The Institutional Animal Care and Use Committee of Peking University People\'s Hospital approved this animal study. To obtain the relationship between SBR and the injection time of ICG and that between SBR and the dose of ICG, we allocated the ten rabbits to two group. One group was the dose group and the other group was the timing group.

Patients
--------

The subjects comprised 15 eligible patients who were scheduled for video-assisted thoracoscopic surgery at Peking University People\'s Hospital between July 2015 and June 2016. The characteristics of the patients are shown in Table [1](#T1){ref-type="table"}. The inclusion criteria were as follows: age between 18 and 75, pulmonary nodules scheduled for thoracoscopy or thoracotomy, preoperatively normal liver function, no ICG or iodine allergies, negative findings on an ICG skin test, volunteering to participate in this study, and providing signed informed consent. The exclusion criteria were preoperative liver dysfunction, ICG or iodine allergies, positive results on an ICG skin test, other well-controlled comorbidities, and being deemed unsuitable for enrolment by the clinicians.

Before surgery, all patients were diagnosed with pulmonary nodules using high-resolution computed tomography with 1 mm slice thickness. All patients provided signed informed consent. The Peking University People\'s Hospital Institutional Review Board authorized this study (2015PHB157-01). The Clinical Trials number for the study is NCT02611245.

Administration of Contrast Agents
---------------------------------

ICG (25 mg vials) was purchased from Tianyi Pharmaceutical Co., Ltd. (Liaoning, China). First, the rabbits in the timing group were injected with 10 mg/kg ICG in sterile water for injection (SWI) 24, 22, 20, 18, and 16 h preoperatively through the marginal ear vein. After calculating the SBR for each time point, the rabbits in the dose group were then injected with 7, 8.5, 10, 11.5, and 13 mg/kg of ICG in SWI 20 h preoperatively.

For patients\' safety reasons, we referred to several studies [@B30]-[@B34] in tumor identification for pulmonary nodules and brain tumors and then chose the ICG concentration of 5 mg/kg. Three patients were respectively injected 5 mg/kg ICG 16, 20 and 24 h preoperatively. Through observation, we determined 5 mg/kg and 24 h preoperatively was the best combination. Then 15 patients were intravenously injected with 5 mg/kg of ICG 24 h preoperatively. No adverse reactions or allergic reactions were observed in any of the subjects.

Preclinical Imaging Procedure
-----------------------------

After routine injection of ICG preoperatively, the rabbits were injected with 6 mg/kg of 0.7% sodium pentobarbital solution in the marginal ear vein. Upon disappearance of the corneal reflex, the rabbits were executed by injection of 50 mL of air through veins. A median thoracotomy was performed. The lung, heart, and aorta were then dissected and removed. The sympathetic nerves on either side of the spine were exposed. Lastly, the spine was cut from the thoracic apex to the diaphragm, and the ribs were cut 3 cm from the spine. The entire chest wall with contact parietal pleura was removed. Then the specimens were washed using physiological saline solution.

The dissected specimens were placed on the microscope table. After adjustments of the appropriate imaging distance and field of vision, a color image was captured. We then switched the microscope to NIR mode, turned off all of the laboratory light sources, and obtained a fluorescence image. Finally, under the guidance of fluorescence signal, we carefully removed the ICG-stained thoracic sympathetic ganglia and the chains on both sides of the spine.

Clinical Imaging Procedure
--------------------------

After the scheduled injection of ICG, the patients were placed in a lateral position and underwent double-catheter trachea insertion under general anesthesia. After routine disinfection, the thoracoscope was inserted at the seventh rib. Before the lung excision operation, the lung was pulled to the front and the posterior mediastinum was revealed. The sympathetic nerves were then explored from top to bottom. We determined and recorded the positions and fluorescence intensities of SG through T6 and the chains in between. Patient No. 11 was diagnosed with pulmonary nodules and posterior mediastinal tumor. After the lung nodules were removed, the mediastinal tumor and T3 were resected together, as they were too close to each other to separate. All excised specimens were then sent to the pathology department.

Histopathologic Assessment
--------------------------

All of the dissected specimens were fixed in 10% phosphate-buffered formalin for 24 h. Paraffin-embedded tissues were consecutively sliced at 5 μm intervals. First, the pathologist analyzed the unstained sections. The sections were then stained with hematoxylin-eosin (H&E) and examined according to the standard pathology protocol. This is because H&E staining may compromise the observation of the ICG fluorescence signal. Areas of the section with fluorescence signals merged with staining of the neurocyte were identified. In addition, we used tyrosine hydroxylase (TH) antibodies (Rabbit polyclonal anti-TH antibody, ab112, Abcam) to identify sympathetic ganglion cells and confirmed our findings [@B35].

Statistical Analysis
--------------------

SBR of thoracic sympathetic nerves were calculated by the method as follows: Firstly, we used ImageJ (Image processing Software, National Institutes of Health, USA) to delineate ganglions or chains as a region of interest (ROI) and calculated the mean brightness value of ROI (V~Signal~). Meanwhile, the surrounding background region was highlighted and the mean brightness value of this region (V~Backgroud~) was also measured. SBR values for each thoracic sympathetic ganglion or chain were calculated six times to reduce errors by dividing V~Signal~ by V~Backgroud~. The Kruskal-Wallis test was used to compare multiple independent samples. To maintain consistency in our calculations, we selected the bilateral second to fifth thoracic sympathetic ganglia (T2, T3, T4, and T5) and used their average value to denote each rabbit\'s SBR. We adopted this approach because the area and intensity of the NIR laser source were limited. Data analysis and graphing were performed using OriginPro 2016 (OriginLab Corporation, USA). P-values \< 0.050 were considered statistically significant.

Results
=======

Preclinical Study Results
-------------------------

The microscopic examinations enabled us to identify each rabbit\'s T2 to T5 ganglia (8 in total) on both sides of the spine. All of the sympathetic ganglia and the chains between them were identified using our FI method on the surface of the specimens. The areas with high SBR values in the fluorescence images matched the thoracic nerves as seen in the color images perfectly (Fig. [1](#F1){ref-type="fig"}B) and confirmed our findings. Shorter time intervals between the ICG injection and the operation led to stronger fluorescence signals in the rabbits in the timing group. However, the SBR for the rabbit injected with ICG 20 h preoperatively was the highest in the group (*p* \< 0.001, Fig. [2](#F2){ref-type="fig"}A). In the dose group, larger doses of ICG led to stronger fluorescence signals. However, the SBR for the rabbit injected with 10 mg/kg of ICG was the highest in the group (*p* \< 0.001, Fig. [2](#F2){ref-type="fig"}B). In the process of statistical analysis, *n* values of the number of samples are all equal to six.

Fluorescence microscopy confirmed the presence of fluorescence in the specimens (Fig. [2](#F2){ref-type="fig"}C), which were resected under the guidance of the fluorescence signal. We found large numbers of neurocytes in the areas with strong fluorescence signals (Fig. [2](#F2){ref-type="fig"}D). However, there were a few nerve cells in areas with weak fluorescence signals. We used pathological examination to verify our findings.

Clinical Trial Results
----------------------

We used ITSN with ICG to successfully identify the thoracic sympathetic ganglia SG to T6 (12 in total) and the chains in between in each patient (Figs. [3](#F3){ref-type="fig"}B-D). The mean SBR value for all ganglia was 3.26 (standard deviation: 0.57), which was sufficiently high to assist the surgeons in identifying the ganglia during surgery. Moreover, the strong fluorescence signal lasted for longer than five hours. The calculated SBR values for SG through T6 for all subjects are shown in Fig. [4](#F4){ref-type="fig"}A. The SBR value for SG was the lowest (*p* \< 0.001) and those for T2 to T6 were not significantly different from each other (*p* \> 0.050). In the process of data statistics, *n* values of the number of samples are all equal to 30.

Fluorescence microscopy enabled us to find a strong fluorescence signal in the paraffin section from the thoracic sympathetic nerve specimen from patient No. 11 (Fig. [4](#F4){ref-type="fig"}B-D). The fluorescence was mainly distributed in areas with large numbers of nerve cells. H&E staining of the section confirmed our findings (Fig. [4](#F4){ref-type="fig"}E).

Discussion
==========

Here we investigated the feasibility and validity of intraoperative ITSN with ICG in both a preclinical study and a clinical trial. We were able to identify T2 to T5 on both sides of the spine in each rabbit and obtained the relationship between SBR and the injection time of ICG and that between SBR and the dose of ICG in the preclinical study. The false-negative rate was 0% (0/10 rabbits). We used the method described here to successfully identify the thoracic sympathetic ganglia SG through T6 (12 in total) and the chains in between in each patient in the clinical study. High SBR values in ITSN with ICG highly depend on the ICG dose, imaging timing, and the sensitivity of the imaging system. Therefore, we developed a modified fluorescence microscope system and an NIR and white-light dual-channel thoracoscope system especially optimized for NIR light collection efficiency. The combination of intraoperative ITSN with ICG and the novel thoracoscope system displayed enormous potential in clinical application.

The novel method described here has several advantages when compared to traditional approaches. First, the high-SBR and intraoperative real-time imaging contributes to the objective and accurate identification of thoracic sympathetic nerves during surgery. Second, NIR light can penetrate much deeper into blood and tissue than visible light. In addition, autofluorescence is very weak in this spectral range. Lastly, this method is minimally invasive and does not interfere with the conventional surgical procedure. Moreover, no adverse reactions or allergic reactions occurred in this study.

ICG is a water-soluble compound with a molecular weight of 755 Da and has been clinically approved for longer than 60 years by the FDA. When injected into the human vein, it binds intensely to high-density lipoprotein and low-density lipoprotein [@B36]. Its half-life is 150-180 s. According to the National Cancer Institute, ICG is excreted from the circulation exclusively by the liver into bile. At first, ICG was mainly used to determine cardiac output and hepatic function. In 2009, Ishizawa *et al.* reported the presence of illuminated liver tumors using ICG [@B37]. These tumors emitted light that peaked at around 830 nm when excited with NIR light. Nowadays, ICG FI plays an important role in sentinel lymph node detection [@B38], [@B39], lymphedema diagnosis and management [@B40], tumor identification [@B41] and organ perfusion assessment [@B42]. In this study, we for the first time used ICG FI to identify the thoracic sympathetic nerves.

Based on the properties of ICG and our preliminary studies, we believe that the high-SBR fluorescence signal from the thoracic sympathetic nerves may result from the specific structure of these nerves. There is a layer of connective tissue membrane containing blood vessels, nerves, and fat cells on the sympathetic ganglion surface. This later may lead to enhanced permeability and retention (EPR) of ICG, similar to certain types of cancer tissue [@B43], [@B44]. This phenomenon is more marked in humans than in rabbits, perhaps due to the larger sizes of the sympathetic nerves. Notably, the SBR value for the SG is lower than that for T2 through T6. This is because there is a fat pad in the hemithorax vertex that often covers the SG.

The EPR effect, firstly reported by Maeda *et al.*, is a property that protein-bound molecules and other nano-sized materials passively accumulate in tumors after systemic administration [@B45]. Ideally, nerve-specific contrast agents should be adopted during nerve-sparing FI surgery. Nowadays, Whitney *et al.* are utilizing NIR fluorescent peptides that bind to nerve sheaths to develop nerve-specific agents on rat model [@B46]. And Gibbs-Strauss *et al.* are developing nerve-specific agents based on small, hydrophobic molecules that bind to the myelin of neurons on animal model [@B47]. However, no clinical trial has ever been reported on nerve-specific contrast agents.

Structurally, thoracic sympathetic nerves are important parts of the sympathetic nervous system and have both white and gray matter rami communicates [@B48]. Functionally, thoracic sympathetic nerves provide sympathetic innervation to the internal organs of the chest. Intraoperative real-time ITSN is conducive to the preservation of the nerves during certain surgeries, such as mediastinal tumor surgery, which is equally crucial to achieving optimal prognosis [@B16]. In addition, ITSN is critical for the accurate ablation or resection of ganglia and chains and in the diagnosis and treatment of related diseases. Moreover, this technique has huge potential for the development of novel therapeutic modalities. In our future work, we will further optimize the dose of ICG and the sensitivity of our imaging system, and attempt to use this method to visualize other nerves.

Conclusion
==========

In this study, we successfully identified thoracic sympathetic nerves using ITSN with ICG in both preclinical and clinical studies. Moreover, the relationship between SBR and the injection time of ICG and that between SBR and the dose of ICG were explored, and a novel NIR and white-light dual-channel thoracoscope system was developed. Pathological studies confirmed our findings. This new method may replace the rib-oriented method as standard practice for the identification of the thoracic sympathetic nerves.
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![(A) Photograph of the modified fluorescence microscope system. (B) *Ex vivo* imaging of the rabbit\'s thoracic sympathetic nerve, including color, fluorescence, and merged images. NIR CCD: near-infrared charge-coupled device.](thnov08p0304g001){#F1}

![(A) The relationship between SBR and the injection time in each rabbit in the timing group. (B) The relationship between SBR and the dose of ICG in each rabbit in the dose group. (C) Representative fluorescence image of a paraffin section of a rabbit\'s thoracic sympathetic nerves. (D) H&E-stained cross-section of the area marked by the dotted box in Fig. [2](#F2){ref-type="fig"}C. SBR: signal to background ratio.](thnov08p0304g002){#F2}

![(A) A picture of the dual-channel thoracoscope system. (B-D) *In vivo* thoracic sympathetic nerve images of a patient, including color, fluorescence, and merged images.](thnov08p0304g003){#F3}

![(A) The SBR values for SG to T6 for all patients. (B-D) Fluorescence, color and merged images of a paraffin section of the thoracic sympathetic nerve specimen from patient No. 11. (E) H&E-stained section of the area shown in Fig. [4](#F4){ref-type="fig"}C. SBR: signal to background ratio.](thnov08p0304g004){#F4}

###### 

Characteristics of the 15 patients who participated in this study

  Study no.   Age   Sex   BMI     History of allergy   Tumor size (cm)   Tumor location   Pathology
  ----------- ----- ----- ------- -------------------- ----------------- ---------------- -----------
  1           52    M     25.76   NO                   1\*0.5            RUL              ADE
  2           33    F     20.07   NO                   1.2\*0.7          LLL              CRC
  3           74    F     25.01   NO                   0.7\*0.6          LUL              ADE
  4           44    F     23.44   NO                   0.6\*0.5          RUL              AIS
  5           30    M     19.69   NO                   2\*1              RML              CHO
  6           63    M     26.99   NO                   2.5\*2            RML              CCRCC
  7           65    F     19.53   NO                   1.5\*1            RLL              AIS
  8           43    F     23.62   YES                  5\*4              RLL              ADE
  9           61    F     23.44   NO                   3\*2              LUL              HCC
  10          57    F     20.03   NO                   0.6\*0.4          RUL              ADE
  11          52    M     25.59   NO                   4\*3              LML              HCC
  12          61    F     26.37   NO                   2.5\*2            RLL              ADE
  13          52    M     22.68   NO                   5\*4              RLL              ADE
  14          50    F     22.32   NO                   5\*3              LLL              ADE
  15          67    F     20.83   NO                   3.2\*2.2          RUL              ADE

ADE: adenocarcinoma; AIS: adenocarcinoma *in situ*; CCRCC: clear cell renal cell carcinoma; CHO: chondrosarcoma; CRC: colorectal cancer; F: female; HCC: hepatocellular carcinoma; LLL: left lower lobe;

LML: left middle lobe; LUL: left upper lobe; M: male; RLL: right lower lobe; RML: right middle lobe; RUL: right upper lobe
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